Cases 31 - 40 of 130
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2022cv03212
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THE ESTATE OF CONNIE KEEP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02461
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:
AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
EISAI CO., LTD. et al v. HETERO USA INC. et al
as 1:2022cv01795
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
HETERO USA INC., HETERO LABS LIMITED and HETERO LABS LIMITED UNIT-III
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. et al v. Hetero Labs Limited et al
as 1:2022cv00378
Plaintiff:
Merck Sharp & Dohme Corp., MSD International Business GmbH, MSD International GmbH and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Hetero USA Inc. et al
as 1:2021cv01760
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit III
Cause Of Action: 35 U.S.C. § 271
Given v. Torrent Pharmaceutical Limited et al
as 1:2021cv20286
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
Daniel Given
Defendant:
Torrent Pharmaceutical Limited, TORRENT PHARMA INC., HETERO USA INC. and others
Cause Of Action: 28 U.S.C. § 1332
Celgene Corporation v. Hetero Labs Limited
as 21-2335
Plaintiff / Appellant:
CELGENE CORPORATION
Defendant / Appellee:
HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
![Final or Interim Order We have downloadable decisions or orders for this case](/bundles/docketsbrowsing/images/gavel.png)
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Payne v. Camber Pharmaceuticals Inc et al
as 1:2021cv15129
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
Ulysses Payne
Defendant:
CAMBER PHARMACEUTICALS INC., HETERO LABS LIMITED, HETERO USA INC. and others
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.